Orthofix Medical Inc. Revenue
Orthofix Medical Inc. (OFIX) reported Revenue of $210.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $210.93M, a 3.85% increase year-over-year.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $196.71M, a 1.58% increase year-over-year.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $219.91M, a 1.97% increase year-over-year.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $205.63M, a 4.59% increase year-over-year.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $822.31M, a 2.85% increase from fiscal 2024.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $799.49M, a 7.08% increase from fiscal 2023.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $746.64M, a 62.06% increase from fiscal 2022.
- Orthofix Medical Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $460.71M, a 0.81% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $210.93M 10-Q · filed 2026-08-05 | $407.64M 10-Q · filed 2026-08-05 | $627.55M derived: sum of 3 quarters · filed 2026-08-05 | $833.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $196.71M 10-Q · filed 2026-05-05 | $416.62M derived: sum of 2 quarters · filed 2026-05-05 | $622.25M derived: sum of 3 quarters · filed 2026-05-05 | $825.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $219.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $425.55M derived: sum of 2 quarters · filed 2026-02-24 | $628.67M derived: sum of 3 quarters · filed 2026-08-05 | $822.31M 10-K · filed 2026-02-24 |
| 2025-09-30 | $205.63M 10-Q · filed 2025-11-04 | $408.75M derived: sum of 2 quarters · filed 2026-08-05 | $602.40M 10-Q · filed 2025-11-04 | $818.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $203.12M 10-Q · filed 2026-08-05 | $396.77M 10-Q · filed 2026-08-05 | $612.42M derived: sum of 3 quarters · filed 2026-08-05 | $809.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $193.65M 10-Q · filed 2026-05-05 | $409.30M derived: sum of 2 quarters · filed 2026-05-05 | $605.91M derived: sum of 3 quarters · filed 2026-05-05 | $804.53M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $215.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $412.26M derived: sum of 2 quarters · filed 2026-02-24 | $610.88M derived: sum of 3 quarters · filed 2026-02-24 | $799.49M 10-K · filed 2026-02-24 |
| 2024-09-30 | $196.61M 10-Q · filed 2025-11-04 | $395.23M derived: sum of 2 quarters · filed 2025-11-04 | $583.83M 10-Q · filed 2025-11-04 | $784.25M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $198.62M 10-Q · filed 2025-08-05 | $387.23M 10-Q · filed 2025-08-05 | $587.64M derived: sum of 3 quarters · filed 2026-02-24 | $771.65M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $188.61M 10-Q · filed 2025-05-06 | $389.02M derived: sum of 2 quarters · filed 2026-02-24 | $573.03M derived: sum of 3 quarters · filed 2026-02-24 | $760.04M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $200.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $384.42M derived: sum of 2 quarters · filed 2026-02-24 | $571.44M derived: sum of 3 quarters · filed 2026-02-24 | $746.64M 10-K · filed 2026-02-24 |
| 2023-09-30 | $184.01M 10-Q · filed 2024-11-07 | $371.02M derived: sum of 2 quarters · filed 2024-11-07 | $546.23M 10-Q · filed 2024-11-07 | $668.46M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $187.02M 10-Q · filed 2024-08-06 | $362.22M 10-Q · filed 2024-08-06 | $484.45M derived: sum of 3 quarters · filed 2025-02-25 | $598.45M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $175.20M 10-Q · filed 2024-05-07 | $297.43M derived: sum of 2 quarters · filed 2025-02-25 | $411.43M derived: sum of 3 quarters · filed 2025-02-25 | $529.50M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $122.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $236.22M derived: sum of 2 quarters · filed 2025-02-25 | $354.30M derived: sum of 3 quarters · filed 2025-02-25 | $460.71M 10-K · filed 2025-02-25 |
| 2022-09-30 | $114.00M 10-Q · filed 2023-11-08 | $232.07M derived: sum of 2 quarters · filed 2023-11-08 | $338.48M 10-Q · filed 2023-11-08 | $463.55M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $118.07M 10-Q · filed 2023-08-08 | $224.49M 10-Q · filed 2023-08-08 | $349.55M derived: sum of 3 quarters · filed 2024-03-05 | $461.98M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $106.42M 10-Q · filed 2023-05-09 | $231.48M derived: sum of 2 quarters · filed 2024-03-05 | $343.91M derived: sum of 3 quarters · filed 2024-03-05 | $465.30M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $125.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $237.49M derived: sum of 2 quarters · filed 2024-03-05 | $358.89M derived: sum of 3 quarters · filed 2024-03-05 | $464.48M 10-K · filed 2024-03-05 |
| 2021-09-30 | $112.43M 10-Q · filed 2022-11-03 | $233.82M derived: sum of 2 quarters · filed 2022-11-03 | $339.42M 10-Q · filed 2022-11-03 | $457.03M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $121.39M 10-Q · filed 2022-08-05 | $226.99M 10-Q · filed 2022-08-05 | $344.61M derived: sum of 3 quarters · filed 2023-03-06 | $455.59M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $105.59M 10-Q · filed 2022-05-06 | $223.21M derived: sum of 2 quarters · filed 2023-03-06 | $334.20M derived: sum of 3 quarters · filed 2023-03-06 | $407.33M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $117.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $228.60M derived: sum of 2 quarters · filed 2023-03-06 | $301.74M derived: sum of 3 quarters · filed 2023-03-06 | $406.56M 10-K · filed 2023-03-06 |
| 2020-09-30 | $110.98M 10-Q · filed 2021-11-05 | $184.12M derived: sum of 2 quarters · filed 2021-11-05 | $288.94M 10-Q · filed 2021-11-05 | $410.44M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $73.14M 10-Q · filed 2021-08-06 | $177.96M 10-Q · filed 2021-08-06 | $299.45M derived: sum of 3 quarters · filed 2021-08-06 | $412.95M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $104.82M 10-Q · filed 2021-04-30 | $226.32M derived: sum of 2 quarters · filed 2021-04-30 | $339.82M derived: sum of 3 quarters · filed 2021-04-30 | $455.67M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $121.49M 10-K · filed 2020-02-24 | $234.99M derived: sum of 2 quarters · filed 2020-11-05 | $350.84M derived: sum of 3 quarters · filed 2020-11-05 | $459.95M 10-K · filed 2022-02-25 |
| 2019-09-30 | $113.50M 10-Q · filed 2020-11-05 | $229.35M derived: sum of 2 quarters · filed 2020-11-05 | $338.46M 10-Q · filed 2020-11-05 | $459.54M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $115.85M 10-Q · filed 2020-08-06 | $224.96M 10-Q · filed 2020-08-06 | $346.04M derived: sum of 3 quarters · filed 2020-08-06 | $457.75M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $109.11M 10-Q · filed 2020-05-08 | $230.19M derived: sum of 2 quarters · filed 2020-05-08 | $341.90M derived: sum of 3 quarters · filed 2020-05-08 | $453.44M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $121.08M 10-K · filed 2020-02-24 | $232.79M derived: sum of 2 quarters · filed 2020-02-24 | $344.33M derived: sum of 3 quarters · filed 2020-02-24 | $453.04M 10-K · filed 2021-02-26 |
| 2018-09-30 | $111.71M 10-K · filed 2020-02-24 | $223.25M derived: sum of 2 quarters · filed 2020-02-24 | $331.96M 10-Q · filed 2019-10-28 | $448.86M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $111.55M 10-K · filed 2020-02-24 | $220.26M 10-Q · filed 2019-08-05 | $337.15M derived: sum of 3 quarters · filed 2020-02-24 | $442.40M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $108.71M 10-K · filed 2020-02-24 | $225.60M derived: sum of 2 quarters · filed 2020-02-24 | $330.85M derived: sum of 3 quarters · filed 2020-02-24 | $439.79M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $116.90M 10-K · filed 2019-02-25 | $222.14M derived: sum of 2 quarters · filed 2019-02-25 | $331.08M derived: sum of 3 quarters · filed 2019-02-25 | $433.82M 10-K · filed 2020-02-24 |
| 2017-09-30 | $105.25M 10-K · filed 2019-02-25 | $214.19M derived: sum of 2 quarters · filed 2019-02-25 | $316.93M 10-Q · filed 2018-10-29 | |
| 2017-06-30 | $108.94M 10-K · filed 2019-02-25 | $211.68M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $102.74M 10-K · filed 2019-02-25 | |||
| 2016-12-31 | $409.79M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |